1. Genetics and Genomics
  2. Neuroscience
Download icon

Investigation of Drosophila fruitless neurons that express Dpr/DIP cell adhesion molecules

  1. Savannah G Brovero
  2. Julia C Fortier
  3. Hongru Hu
  4. Pamela C Lovejoy
  5. Nicole R Newell
  6. Colleen M Palmateer
  7. Ruei-Ying Tzeng
  8. Pei-Tseng Lee
  9. Kai Zinn
  10. Michelle N Arbeitman  Is a corresponding author
  1. Florida State University, United States
  2. Baylor College of Medicine, United States
  3. California Institute of Technology, United States
Research Article
  • Cited 1
  • Views 1,291
  • Annotations
Cite this article as: eLife 2021;10:e63101 doi: 10.7554/eLife.63101

Abstract

Drosophila reproductive behaviors are directed by fruitless neurons. A reanalysis of genomic studies shows that genes encoding dpr and DIP Immunoglobulin superfamily (IgSF) members are expressed in fru P1 neurons. We find that each fru P1 and dpr/DIP (fru P1dpr/DIP) overlapping expression pattern is similar in both sexes, but there are dimorphisms in neuronal morphology and cell number. Behavioral studies of fru P1dpr/DIP perturbation genotypes indicates that the mushroom body functions together with the lateral protocerebral complex to direct courtship behavior. A single-cell RNA-seq analysis of fru P1 neurons shows that many DIPs have high expression in a small set of neurons, whereas the dprs are often expressed in a larger set of neurons at intermediate levels, with a myriad of dpr/DIP expression combinations. Functionally, we find that perturbations of sex hierarchy genes and of DIP-ε change the sex-specific morphologies of fru P1DIP-α neurons.

Data availability

All raw data are provided in the supplementary materials. The sequencing data has been deposited in GEO under accession number GSE162098

The following data sets were generated

Article and author information

Author details

  1. Savannah G Brovero

    Biomedical Sciences, Florida State University, Tallahassee, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Julia C Fortier

    Biomedical Sciences, Florida State University, Tallahassee, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Hongru Hu

    Biomedical Sciences, Florida State University, Tallahassee, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Pamela C Lovejoy

    Biomedical Sciences, Florida State University, Tallahassee, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Nicole R Newell

    Biomedical Sciences, Florida State University, Tallahassee, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Colleen M Palmateer

    Biomedical Sciences, Florida State University, Tallahassee, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Ruei-Ying Tzeng

    Biomedical Sciences, Florida State University, Tallahassee, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Pei-Tseng Lee

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Kai Zinn

    Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6706-5605
  10. Michelle N Arbeitman

    Biomedical Sciences, Florida State University, Tallahassee, United States
    For correspondence
    michelle.arbeitman@med.fsu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2437-4352

Funding

National Institutes of Health (R01 grant number R01GM073039)

  • Savannah G Brovero
  • Julia C Fortier
  • Hongru Hu
  • Pamela C Lovejoy
  • Nicole R Newell
  • Colleen M Palmateer
  • Ruei-Ying Tzeng
  • Michelle N Arbeitman

National Institutes of Health (R03 grant number R03NS090184)

  • Ruei-Ying Tzeng

National Institutes of Health (R01 grant number R01GM073039)

  • Michelle N Arbeitman

Florida State University (R01 grant number Biomedical Sciences)

  • Hongru Hu
  • Pamela C Lovejoy
  • Nicole R Newell
  • Colleen M Palmateer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Michael B Eisen, University of California, Berkeley, United States

Publication history

  1. Received: September 17, 2020
  2. Accepted: February 22, 2021
  3. Accepted Manuscript published: February 22, 2021 (version 1)
  4. Version of Record published: March 18, 2021 (version 2)

Copyright

© 2021, Brovero et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,291
    Page views
  • 156
    Downloads
  • 1
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    David Mauduit et al.
    Research Article

    Understanding how enhancers drive cell type specificity and efficiently identifying them is essential for the development of innovative therapeutic strategies. In melanoma, the melanocytic (MEL) and the mesenchymal-like (MES) states present themselves with different responses to therapy, making the identification of specific enhancers highly relevant. Using massively parallel reporter assays (MPRA) in a panel of patient-derived melanoma lines (MM lines), we set to identify and decipher melanoma enhancers by first focusing on regions with state specific H3K27 acetylation close to differentially expressed genes. An in-depth evaluation of those regions was then pursued by investigating the activity of overlapping ATAC-seq peaks along with a full tiling of the acetylated regions with 190 bp sequences. Activity was observed in more than 60% of the selected regions and we were able to precisely locate the active enhancers within ATAC-seq peaks. Comparison of sequence content with activity, using the deep learning model DeepMEL2, revealed that AP-1 alone is responsible for the MES enhancer activity. In contrast, SOX10 and MITF both influence MEL enhancer function with SOX10 being required to achieve high levels of activity. Overall, our MPRAs shed light on the relationship between long and short sequences in terms of their sequence content, enhancer activity, and specificity across melanoma cell states.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Jeffrey V Wong et al.
    Feature Article

    Making the knowledge contained in scientific papers machine-readable and formally computable would allow researchers to take full advantage of this information by enabling integration with other knowledge sources to support data analysis and interpretation. Here we describe Biofactoid, a web-based platform that allows scientists to specify networks of interactions between genes, their products, and chemical compounds, and then translates this information into a representation suitable for computational analysis, search and discovery. We also report the results of a pilot study to encourage the wide adoption of Biofactoid by the scientific community.